Table 1.
A | B | C | D | E | F | G | H | |
---|---|---|---|---|---|---|---|---|
1 | POS | POS | NEG | NEG | CINC-2 | CINC-3 | CNTF | Fractalkine |
2 | POS | POS | NEG | NEG | CINC-2 | CINC-3 | CNTF | Fractalkine |
3 | GM-CSF | IFN gamma | IL-1 alpha | IL-1 beta | IL-4 | IL-6 | IL-10 | LIX |
4 | GM-CSF | IFN gamma | IL-1 alpha | IL-1 beta | IL-4 | IL-6 | IL-10 | LIX |
5 | Leptin | MCP-1 | MIP-3 alpha | beta NGF | TIMP-1 | TNF alpha | VEGF | BLANK |
6 | Leptin | MCP-1 | MIP-3 alpha | beta NGF | TIMP-1 | TNF alpha | VEGF | BLANK |
7 | BLANK | BLANK | BLANK | BLANK | BLANK | BLANK | BLANK | POS |
8 | BLANK | BLANK | BLANK | BLANK | BLANK | BLANK | BLANK | POS |
Cytokine-Induced Neutrophil Chemoattractant-2 (CINC-2); Cytokine-Induced Neutrophil Chemoattractant-3 (CINC-3); Ciliary neurotrophic factor (CNTF); Granulocyte-macrophage colony-stimulating factor (GM-CSF); Interleukins (IL-1α, IL-1β IL-4, IL-6, IL-10); Interferon gamma (IFN gamma); Lipopolysaccharide-inducible CXC chemokine (LIX); Monocyte chemotactic protein-1 (MCP-1); Macrophage Inflammatory Protein-3 (MIP-3 alpha); Nerve growth factor-beta (β-NGF); Tissue inhibitor of metalloproteinases (TIMP-1); Tumor necrosis factor alpha (TNF alpha); Vascular endothelial growth factor (VEGF). Positive and negative control spots (POS and NEG, respectively).